Xu R - Search Results

1

Knockout of cardiac troponin I-interacting kinase leads to cardiac dysfunction and remodelling.

Qu H, Zhang Y, Zhang W, Zhu Y, Xu R. Qu H, et al. Among authors: xu r. Clin Exp Pharmacol Physiol. 2022 Nov;49(11):1169-1178. doi: 10.1111/1440-1681.13699. Epub 2022 Jul 22. Clin Exp Pharmacol Physiol. 2022. PMID: 35781726

2

Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms.

Xu RX, Chen X, Chen JH, Han Y, Han BM. Xu RX, et al. Clin Exp Pharmacol Physiol. 2009 Feb;36(2):176-80. doi: 10.1111/j.1440-1681.2008.05041.x. Epub 2008 Sep 10. Clin Exp Pharmacol Physiol. 2009. PMID: 18785984

3

Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy.

Wang L, Wang H, Ye J, Xu RX, Song L, Shi N, Zhang YW, Chen X, Meng XM. Wang L, et al. Clin Exp Pharmacol Physiol. 2011 Apr;38(4):278-84. doi: 10.1111/j.1440-1681.2011.05499.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21314842

4

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I.

Wang H, Wang L, Song L, Zhang YW, Ye J, Xu RX, Shi N, Meng XM. Wang H, et al. Braz J Med Biol Res. 2013 Feb;46(2):128-37. doi: 10.1590/1414-431X20122515. Epub 2013 Feb 1. Braz J Med Biol Res. 2013. PMID: 23369981 Free PMC article.

5

Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.

Xu RX, Guo YL, Li XL, Li S, Li JJ. Xu RX, et al. Clin Exp Pharmacol Physiol. 2014 Jul;41(7):475-81. doi: 10.1111/1440-1681.12243. Clin Exp Pharmacol Physiol. 2014. PMID: 24739131 Clinical Trial.

6

Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway.

Wu YR, Shi XY, Ma CY, Zhang Y, Xu RX, Li JJ. Wu YR, et al. Cardiovasc Diabetol. 2019 Nov 9;18(1):146. doi: 10.1186/s12933-019-0954-6. Cardiovasc Diabetol. 2019. PMID: 31706303 Free PMC article.

7

Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis.

Xu RX, Zhang Y, Zhang Y, Wu YR, Li XL, Guo YL, Liu G, Dong Q, Li JJ. Xu RX, et al. Curr Med Sci. 2020 Oct;40(5):879-884. doi: 10.1007/s11596-020-2263-4. Epub 2020 Oct 29. Curr Med Sci. 2020. PMID: 33123903

8

Diallyl disulfide improves lipid metabolism by inhibiting PCSK9 expression and increasing LDL uptake via PI3K/Akt-SREBP2 pathway in HepG2 cells.

Wu YR, Li L, Sun XC, Wang J, Ma CY, Zhang Y, Qu HL, Xu RX, Li JJ. Wu YR, et al. Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):322-332. doi: 10.1016/j.numecd.2020.08.012. Epub 2020 Aug 20. Nutr Metab Cardiovasc Dis. 2021. PMID: 33500108 Free article.

9

Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE^-/- mice by down-regulating PCSK9 via ERK1/2 pathway.

Ma CY, Shi XY, Wu YR, Zhang Y, Yao YH, Qu HL, Zhang W, Guo YL, Xu RX, Li JJ. Ma CY, et al. Ann Transl Med. 2021 Oct;9(20):1517. doi: 10.21037/atm-20-8106. Ann Transl Med. 2021. PMID: 34790723 Free PMC article.

10

The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: An age- and gender-matched case-control study.

Zhang W, Jin J, Zhang H, Zhu Y, Dong Q, Sun J, Guo Y, Dou K, Xu R, Li J. Zhang W, et al. Among authors: xu r. Front Endocrinol (Lausanne). 2023 Jan 12;13:1041555. doi: 10.3389/fendo.2022.1041555. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36714594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,584 results

Search Page

Filters